Evidence map›Paper›PMID 29500907›Full record

ArticleLiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society2018

Alterations in gut microbial function following liver transplant.

Jasmohan S Bajaj, Genta Kakiyama, I Jane Cox, Hiroshi Nittono, Hajime Takei, Melanie White, Andrew Fagan, Edith A Gavis, Douglas M Heuman, Ho Chong Gilles and 9 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Journal of clinical medicine · 2022
    Review
  17. Review
  18. Review
  19. Promises of microbiome-based therapies.Journal of hepatology · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 3 countries.

Jasmohan S BajajDivision of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire Veterans Affairs Medical Center, Richmond, VA.ORCID 0000-0003-4928-3681
Genta KakiyamaDivision of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire Veterans Affairs Medical Center, Richmond, VA.
I Jane CoxInstitute of Hepatology, Foundation for Liver Research, London, United Kingdom.ORCID 0000-0002-9828-7235
Hiroshi NittonoJunshin Clinic Bile Acid Institute, Tokyo, Japan.
Hajime TakeiJunshin Clinic Bile Acid Institute, Tokyo, Japan.
Melanie WhiteDivision of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire Veterans Affairs Medical Center, Richmond, VA.
Andrew FaganDivision of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire Veterans Affairs Medical Center, Richmond, VA.
Edith A GavisDivision of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire Veterans Affairs Medical Center, Richmond, VA.
Douglas M HeumanDivision of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire Veterans Affairs Medical Center, Richmond, VA.
Ho Chong GillesDivision of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire Veterans Affairs Medical Center, Richmond, VA.
Phillip HylemonDivision of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire Veterans Affairs Medical Center, Richmond, VA.
Simon D Taylor-RobinsonImperial College, London, United Kingdom.
Cristina Legido-QuigleyFaculty of Life Sciences and Medicine, King's College, London, United Kingdom.
Min KimFaculty of Life Sciences and Medicine, King's College, London, United Kingdom.
Jin XuFaculty of Life Sciences and Medicine, King's College, London, United Kingdom.
Roger WilliamsInstitute of Hepatology, Foundation for Liver Research, London, United Kingdom.
Masoumeh SikaroodiMicrobiome Analysis Center, George Mason University, Manassas, VA.
William M PandakDivision of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire Veterans Affairs Medical Center, Richmond, VA.
Patrick M GillevetMicrobiome Analysis Center, George Mason University, Manassas, VA.
Virginia Commonwealth University · USKing's College London · GBFoundation for Liver Research · GBGeorge Mason University · USTokyo Junshin University · JPImperial College London · GB

Funding

Spectrum of Neuro-Cognitive Impairment in CirrhosisR01DK087913 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI BAJAJ, JASMOHAN S · 2011 to 2015
$2.0M
Modulation of Gut-Brain Axis Using Fecal Microbiome Transplant Capsules in CirrhosisR21TR002024 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI BAJAJ, JASMOHAN S · 2017 to 2018
$414k
Role of Bile Acids and Gut Bacteria in GI DiseasesI01BX001328 · VA · VA VETERANS ADMINISTRATION HOSPITAL · PI HYLEMON, PHILLIP B · 2012 to 2020
–
Fecal Microbiota Transplant in Veterans with CirrhosisI01CX001076 · VA · VA VETERANS ADMINISTRATION HOSPITAL · PI BAJAJ, JASMOHAN S · 2015 to 2024
–
BLRD VA I01 BX000197BLRD VA I01 BX001328CSRD VA I01 CX001076NCATS NIH HHS R21 TR002024NIDDK NIH HHS R01 DK087913
6 · The paper itself

Abstract

Liver transplantation (LT) improves daily function and ameliorates gut microbial composition. However, the effect of LT on microbial functionality, which can be related to overall patient benefit, is unclear and could affect the post-LT course. The aims were to determine the effect of LT on gut microbial functionality focusing on endotoxemia, bile acid (BA), ammonia metabolism, and lipidomics. We enrolled outpatient patients with cirrhosis on the LT list and followed them until 6 months after LT. Microbiota composition (Shannon diversity and individual taxa) and function analysis (serum endotoxin, urinary metabolomics and serum lipidomics, and stool BA profile) and cognitive tests were performed at both visits. We enrolled 40 patients (age, 56 ± 7 years; mean Model for End-Stage Liver Disease score, 22.6). They received LT 6 ± 3 months after enrollment and were re-evaluated 7 ± 3 months after LT with a stable course. A significant improvement in cognition with increase in microbial diversity, increase in autochthonous and decrease in potentially pathogenic taxa, and reduced endotoxemia were seen after LT compared with baseline. Stool BAs increased significantly after LT, and there was evidence of greater bacterial action (higher secondary, oxo and iso-BAs) after LT although the levels of conjugated BAs remained similar. There was a reduced serum ammonia and corresponding rise in urinary phenylacetylglutamine after LT. There was an increase in urinary trimethylamine-N-oxide, which was correlated with specific changes in serum lipids related to cell membrane products. The ultimate post-LT lipidomic profile appeared beneficial compared with the profile before LT. In conclusion, LT improves gut microbiota diversity and dysbiosis, which is accompanied by favorable changes in gut microbial functionality corresponding to BAs, ammonia, endotoxemia, lipidomic, and metabolomic profiles. Liver Transplantation 24 752-761 2018 AASLD.

Indexed as

Liver TransplantationBile Acids and SaltsCognitionDysbiosisEndotoxemiaEnd Stage Liver DiseaseFecesFemaleGastrointestinal MicrobiomeHumansLipid MetabolismLiverLiver CirrhosisLiver Function TestsMaleMetabolomeBile Acids and Salts

Identifiers

PMID29500907
PMCPMC5992060
OpenAlexW2791083955

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.